These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Delayed detection of ventricular tachycardia in a dual chamber rate adaptive pacing implantable cardioverter defibrillator: a case of intradevice interaction. Shalaby AA Pacing Clin Electrophysiol; 2004 Aug; 27(8):1164-6. PubMed ID: 15305971 [TBL] [Abstract][Full Text] [Related]
7. Delayed detection of ventricular tachycardia in a dual chamber rate adaptive pacing implantable cardioverter defibrillator: a case of intradevice interaction. Strohmer B Pacing Clin Electrophysiol; 2005 Jan; 28(1):76-7. PubMed ID: 15660811 [No Abstract] [Full Text] [Related]
8. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. Wilkoff BL; Cook JR; Epstein AE; Greene HL; Hallstrom AP; Hsia H; Kutalek SP; Sharma A; JAMA; 2002 Dec; 288(24):3115-23. PubMed ID: 12495391 [TBL] [Abstract][Full Text] [Related]
9. Interruption of Pacing Following Nonsustained Ventricular Tachycardia in an AAI Programmed Implantable Cardioverter Defibrillator. Egan P; Wilkoff BL; Tchou P Pacing Clin Electrophysiol; 2015 Sep; 38(9):1082-90. PubMed ID: 26010870 [TBL] [Abstract][Full Text] [Related]
10. Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study. Kolb C; Sturmer M; Sick P; Reif S; Davy JM; Molon G; Schwab JO; Mantovani G; Dan D; Lennerz C; Borri-Brunetto A; Babuty D JACC Heart Fail; 2014 Dec; 2(6):611-9. PubMed ID: 25282033 [TBL] [Abstract][Full Text] [Related]
11. Low inappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results. Auricchio A; Schloss EJ; Kurita T; Meijer A; Gerritse B; Zweibel S; AlSmadi FM; Leng CT; Sterns LD; Heart Rhythm; 2015 May; 12(5):926-36. PubMed ID: 25637563 [TBL] [Abstract][Full Text] [Related]
12. Prevention of inappropriate therapy in implantable cardioverter-defibrillators: results of a prospective, randomized study of tachyarrhythmia detection algorithms. Theuns DA; Klootwijk AP; Goedhart DM; Jordaens LJ J Am Coll Cardiol; 2004 Dec; 44(12):2362-7. PubMed ID: 15607399 [TBL] [Abstract][Full Text] [Related]
14. Inappropriate cardioverter-defibrillator discharge continues to be a major problem in clinical practice. Jodko Ł; Kornacewicz-Jach Z; Kaźmierczak J; Rzeuski R; Zielonka J; Kaliszczak R; Safranow K Cardiol J; 2009; 16(5):432-9. PubMed ID: 19753522 [TBL] [Abstract][Full Text] [Related]
15. First worldwide clinical experience with a new dual chamber implantable cardioverter defibrillator. Advantages and complications. The Ventak AV II DR investigators. Sticherling C; Schaumann A; Klingenheben T; Hohnloser SH Europace; 1999 Apr; 1(2):96-102. PubMed ID: 11233190 [TBL] [Abstract][Full Text] [Related]
16. Failure to deliver a shock in a dual-chamber implantable cardioverter-defibrillator: a case report. Sousa PA; Candeias R; Jesus I Rev Port Cardiol; 2015; 34(7-8):495.e1-5. PubMed ID: 26148668 [TBL] [Abstract][Full Text] [Related]